Clearside Biomedical, Inc.
CLSD
$3.70
-$0.39-9.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.34% | -12.55% | 4.98% | -1.25% | 35.44% |
| Total Depreciation and Amortization | -1.18% | 7.59% | 5.33% | 70.45% | 57.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.53% | 95.88% | -47.19% | 115.00% | -71.13% |
| Change in Net Operating Assets | -133.67% | -354.05% | 125.07% | -415.79% | 140.46% |
| Cash from Operations | 18.89% | -10.96% | 11.14% | -4.10% | 27.65% |
| Capital Expenditure | 100.00% | 97.97% | -737.74% | 87.47% | -642.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 508.68% | 114.55% | -- |
| Cash from Investing | 100.00% | -100.10% | 500.84% | 113.54% | -19,964.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 118.57% | -78.50% | 14,750.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.00% | -- | -- | -- | -- |
| Cash from Financing | 186.26% | -126.60% | 14,750.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.48% | -204.24% | 240.97% | 74.59% | -366.00% |